Susquehanna International Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,700
| Closed | -$160K | – | 12750 |
|
|
2025
Q1 | $160K | Buy |
+10,700
| New | +$179K | ﹤0.01% | 11166 |
|
|
2024
Q4 | – | Sell |
-67,300
| Closed | -$1.25M | – | 12286 |
|
|
2024
Q3 | $1.25M | Buy |
67,300
+10,100
| +18% | +$203K | ﹤0.01% | 6309 |
|
|
2024
Q2 | $1.16M | Sell |
57,200
-55,300
| -49% | -$979K | ﹤0.01% | 6236 |
|
|
2024
Q1 | $1.92M | Buy |
112,500
+59,900
| +114% | +$942K | ﹤0.01% | 5438 |
|
|
2023
Q4 | $929K | Buy |
52,600
+35,200
| +202% | +$709K | ﹤0.01% | 7161 |
|
|
2023
Q3 | $418K | Buy |
17,400
+2,300
| +15% | +$56.5K | ﹤0.01% | 8650 |
|
|
2023
Q2 | $351K | Sell |
15,100
-14,500
| -49% | -$328K | ﹤0.01% | 9119 |
|
|
2023
Q1 | $653K | Buy |
+29,600
| New | +$693K | ﹤0.01% | 7910 |
|
|
2022
Q4 | – | Sell |
-10,600
| Closed | -$143K | – | 12529 |
|
|
2022
Q3 | $143K | Sell |
10,600
-18,100
| -63% | -$305K | ﹤0.01% | 11302 |
|
|
2022
Q2 | $569K | Sell |
28,700
-31,300
| -52% | -$832K | ﹤0.01% | 7941 |
|
|
2022
Q1 | $1.9M | Buy |
60,000
+24,800
| +70% | +$695K | ﹤0.01% | 5595 |
|
|
2021
Q4 | $785K | Buy |
35,200
+7,300
| +26% | +$190K | ﹤0.01% | 7927 |
|
|
2021
Q3 | $774K | Sell |
27,900
-36,400
| -57% | -$1.11M | ﹤0.01% | 8222 |
|
|
2021
Q2 | $2.5M | Buy |
64,300
+29,000
| +82% | +$1.04M | ﹤0.01% | 5413 |
|
|
2021
Q1 | $1.02M | Sell |
35,300
-36,200
| -51% | -$1.24M | ﹤0.01% | 7701 |
|
|
2020
Q4 | $1.9M | Sell |
71,500
-25,200
| -26% | -$515K | ﹤0.01% | 5215 |
|
|
2020
Q3 | $1.48M | Sell |
96,700
-11,500
| -11% | -$241K | ﹤0.01% | 5211 |
|
|
2020
Q2 | $2.2M | Buy |
108,200
+82,700
| +324% | +$1.48M | ﹤0.01% | 4321 |
|
|
2020
Q1 | $264K | Sell |
25,500
-15,300
| -38% | -$428K | ﹤0.01% | 8213 |
|
|
2019
Q4 | $1.54M | Buy |
40,800
+1,800
| +5% | +$80.9K | ﹤0.01% | 4754 |
|
|
2019
Q3 | $1.82M | Sell |
39,000
-9,500
| -20% | -$442K | ﹤0.01% | 4404 |
|
|
2019
Q2 | $2.54M | Sell |
48,500
-13,100
| -21% | -$768K | ﹤0.01% | 3727 |
|
|
2019
Q1 | $4.25M | Buy |
61,600
+47,700
| +343% | +$3.2M | ﹤0.01% | 2652 |
|
|
2018
Q4 | $829K | Sell |
13,900
-86,600
| -86% | -$7.47M | ﹤0.01% | 5044 |
|
|
2018
Q3 | $11.6M | Sell |
100,500
-3,100
| -3% | -$350K | ﹤0.01% | 1781 |
|
|
2018
Q2 | $13.1M | Buy |
103,600
+6,700
| +7% | +$815K | ﹤0.01% | 1678 |
|
|
2018
Q1 | $10.5M | Buy |
96,900
+40,500
| +72% | +$4.48M | ﹤0.01% | 1727 |
|
|
2017
Q4 | $6.18M | Buy |
56,400
+23,600
| +72% | +$2.36M | ﹤0.01% | 2306 |
|
|
2017
Q3 | $3.24M | Sell |
32,800
-10,700
| -25% | -$1.04M | ﹤0.01% | 3115 |
|
|
2017
Q2 | $4.41M | Sell |
43,500
-49,300
| -53% | -$5.32M | ﹤0.01% | 2579 |
|
|
2017
Q1 | $10.7M | Sell |
92,800
-34,900
| -27% | -$4.06M | 0.01% | 1561 |
|
|
2016
Q4 | $15.3M | Sell |
127,700
-14,900
| -10% | -$1.65M | 0.01% | 1240 |
|
|
2016
Q3 | $16M | Buy |
142,600
+26,700
| +23% | +$3.08M | 0.01% | 1178 |
|
|
2016
Q2 | $14.4M | Sell |
115,900
-114,400
| -50% | -$13.8M | 0.01% | 1183 |
|
|
2016
Q1 | $25.9M | Sell |
230,300
-9,400
| -4% | -$977K | 0.01% | 831 |
|
|
2015
Q4 | $26.1M | Buy |
239,700
+8,900
| +4% | +$1.02M | 0.01% | 955 |
|
|
2015
Q3 | $23M | Buy |
230,800
+101,600
| +79% | +$11.1M | 0.01% | 1092 |
|
|
2015
Q2 | $14.7M | Sell |
129,200
-13,600
| -10% | -$1.65M | 0.01% | 1602 |
|
|
2015
Q1 | $14.9M | Buy |
142,800
+88,100
| +161% | +$9.39M | 0.01% | 1496 |
|
|
2014
Q4 | $6.58M | Sell |
54,700
-40,800
| -43% | -$5.36M | ﹤0.01% | 2493 |
|
|
2014
Q3 | $14M | Sell |
95,500
-1,300
| -1% | -$201K | 0.01% | 1750 |
|
|
2014
Q2 | $16.2M | Buy |
96,800
+67,700
| +233% | +$12M | 0.01% | 1586 |
|
|
2014
Q1 | $5.78M | Sell |
29,100
-6,100
| -17% | -$1.15M | ﹤0.01% | 2696 |
|
|
2013
Q4 | $6.72M | Sell |
35,200
-700
| -2% | -$130K | ﹤0.01% | 2530 |
|
|
2013
Q3 | $6.08M | Sell |
35,900
-7,400
| -17% | -$1.15M | ﹤0.01% | 2461 |
|
|
2013
Q2 | $6.57M | Buy |
+43,300
| New | +$6.14M | ﹤0.01% | 2272 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Susquehanna International Group's CLB Position: Q1 2026 in Review
Susquehanna International Group increased its Core Laboratories (CLB) stake by 56% in Q1 2026, buying an estimated $209K and bringing the position to 32,350 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #9447.
Susquehanna International Group first reported a position in CLB in Q2 2013 and has held it in 46 quarters since. The position peaked at $16.9M in Q3 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Susquehanna International Group held 32,350 shares of Core Laboratories worth $543K as of Q1 2026.
- Susquehanna International Group bought 11,657 Core Laboratories shares in Q1 2026, an estimated $209K.
- Core Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9447 holding.
- Susquehanna International Group first reported a position in Core Laboratories in Q2 2013 and has held it in 46 quarters since.
- Susquehanna International Group's Core Laboratories position peaked at $16.9M in Q3 2014.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.